CClinicalTrials.gg
Sign In
Status unknownNCT03786588Updated Aug 29, 2019

Patients With Chronic Pelvic Pain With Vaginal Microbiota

An observational study in Pelvic Pain, sponsored by Peking Union Medical College Hospital. Status unknown at 1 site in China. Open to male participants aged 20 Years to 45 Years. Per ClinicalTrials.gov, last updated 2019-08-29.

Sponsored by Peking Union Medical College Hospital · Observational

The sponsor has not verified this record recently (last verified Aug 2019), so the status shown — last known as Recruiting — may be out of date.
Study type
Observational
Model
Case-control
Time perspective
Prospective
Enrollment
1
Ages
20 Years to 45 Years
Sex
Male
01

Study summary

Vaginal microorganisms play an important role in the occurrence and development of many diseases, such as persistent infection of high-risk human papillomavirus (HR-HPV) causing cervical intraepithelial neoplasia and cervical cancer, and the role of microorganisms in chronic prostatitis.

02

Conditions studied

  • Pelvic Pain

Browse trials for

03

In context

Pelvic Pain

375 studies on the registry are indexed under Pelvic Pain; 83 are open to participants now.

This study's planned enrollment of 1 is below the median of 100 across 87 observational studies indexed under Pelvic Pain.

Browse Pelvic Pain studies →

Lead sponsor

Peking Union Medical College Hospital is the lead sponsor of 1,115 studies on the registry; 463 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 45 Years
Sexes eligible
Male
Sampling method
Probability sample

Study population

Gestational participants without HPV infection

Inclusion criteria

  • Those are aged 20 to 45 years old, have vaginal intercourse more than 3 years, and aren't in menstrual, pregnancy or puerperium period.

Exclusion criteria

Exclusion Criteria:

  • Those are aged more than 45 years old without HPV infection in the last one year, having no vaginal intercourse, and those can't cooperate the examiner. Women who are HIV or hepatitis B/C positive, have autoimmune disorders and systemic disease (like diabetes mellitus, hormone treatment diseases, severe liver and kidney dysfunction), or have severe mental illness and malignant tumors are also excluded. At the same time, all the participants should meet the following requirements: no vagina douching within last 2 days, no vaginal intercourse within last 3 days, no systemic application of antifungal agents or antibiotics or pessaries within last 14 days of sampling.
05

Study design

Observational model
Case-control
Time perspective
Prospective
Enrollment
1 participant (estimated)
Target follow-up
1 Year
Patient registry
Yes

Groups and cohorts

  • Group A

    Vaginal microbiota in gestation CPP women without HPV infection

    Other: Observation

  • GroupB

    Vaginal microbiota in gestation women without CPP and HPV infection

Interventions

  • OtherObservation

    The patients with the negative results of HPV infection, and assigned to different group according to the CPP manifestation.

06

What researchers measure

Primary outcomes

  1. Vaginal microbiota difference

    Vaginal microbiota difference between the women with or without CPP, and all the cases are cervical HPV negative.

    Time frame: one year

07

Study locations

1 of 1 sites recruiting
  • Peking Union Medical College Hospital
    Beijing, Beijing 100730, China
    • Hui Xu · Contact · +86-010-69156874
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 29, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT03786588
Lead sponsor
Peking Union Medical College Hospital
Responsible party
shuwang (Associate Professor, Peking Union Medical College Hospital) — Principal investigator
First posted
Dec 26, 2018
Start date
Dec 25, 2018
Primary completion
Dec 25, 2019 (estimated)
Completion
Dec 25, 2020 (estimated)
Last update
Aug 29, 2019

Study contacts

Shu Wang
Contact
chaoxp_pumch@163.com
+86-18810535568

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Aug 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Pelvic Pain→

Other studies from this sponsor

Peking Union Medical College Hospital

Start the discussion